Peri-infection titers of neutralizing and binding antibodies as a predictor of COVID-19 breakthrough infections in vaccinated healthcare professionals: importance of the timing.
Constant GillotJean-Louis BayartMélanie ClossetJulien CaboVincent MaloteauJean-Michel DognéJonathan DouxfilsJulien FavressePublished in: Clinical chemistry and laboratory medicine (2023)
In conclusion, our results showed that subjects that developed a breakthrough infection had lower levels of neutralizing and total binding antibodies compared to controls. The difference was mostly noticeable considering neutralizing antibodies, especially for infections occurring before 3 months after the booster administration.